Company Dyadic International, Inc.

Equities

DYAI

US26745T1016

Biotechnology & Medical Research

Delayed Nasdaq 09:34:30 2024-03-28 am EDT 5-day change 1st Jan Change
1.65 USD +1.23% Intraday chart for Dyadic International, Inc. +1.23% +2.48%

Business Summary

Dyadic International, Inc. is a global biotechnology platform company with operations in the United States. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It has licensed this technology to third parties, such as Abengoa Bioenergy, BASF,Codexis and others, for industrial applications. This technology is based on the Thermothelomyces heterothallica fungus, namely C1. The C1-cell protein production platform is a robust and versatile thermophilic filamentous fungal expression system for the development and production of biologic products, including enzymes and other proteins for human and animal health. The Company also developed the Dapibus thermophilic filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of proteins, metabolites and other biologic products for use in non-pharmaceutical applications, such as food, nutrition and wellness.

Number of employees: 7

Sales per Business

USD in Million2021Weight2022Weight Delta
Industrial Enzymes and Other Proteins
100.0 %
2 100.0 % 3 100.0 % +21.90%

Sales per region

USD in Million2021Weight2022Weight Delta
United States and Netherlands
100.0 %
2 100.0 % 3 100.0 % +21.90%

Managers

Managers TitleAgeSince
Founder 69 78-12-31
Director of Finance/CFO 48 16-05-31
Chief Tech/Sci/R&D Officer 66 14-05-05
Corporate Officer/Principal - 23-10-08
Corporate Officer/Principal 48 21-11-08

Members of the board

Members of the board TitleAgeSince
Founder 69 78-12-31
Director/Board Member 80 15-04-30
Chairman 69 14-06-11
Director/Board Member 56 21-01-07
Director/Board Member 66 08-06-19
Director/Board Member 76 18-01-02
Director/Board Member 71 16-08-14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 41,064,563 20,067,365 ( 48.87 %) 12,253,502 ( 29.84 %) 48.87 %

Shareholders

NameEquities%Valuation
4,532,493 15.73 % 6 M $
3,548,528 12.32 % 5 M $
Bandera Partners LLC
5.439 %
1,566,908 5.439 % 2 M $
Chapin Davis, Inc.
2.868 %
826,301 2.868 % 1 M $
Vanguard Global Advisers LLC
2.790 %
803,917 2.790 % 1 M $
Northeast Financial Consultants, Inc.
0.8677 %
250,000 0.8677 % 337 500 $
BlackRock Institutional Trust Co. NA
0.8512 %
245,250 0.8512 % 331 088 $
Geode Capital Management LLC
0.7730 %
222,696 0.7730 % 300 640 $
216,103 0.7501 % 291 739 $
Seth Herbst
0.4588 %
132,174 0.4588 % 178 435 $

Company contact information

Dyadic International, Inc.

1044 North US Highway One Suite 201

33477-5094, Jupiter

+

http://www.dyadic.com
address Dyadic International, Inc.(DYAI)